Annual conference for RUNX1 familial platelet disorder and related research
Official title: The RUNX1 Research Program 8th Annual Scientific Conference and Patient Meeting
Funded at Runx1 Foundation · NIH-11000227 · Data updated 2026-11-12
This conference is a friendly gathering for researchers, doctors, and patients to share the latest information about RUNX1 familial platelet disorder, a rare condition that can raise the risk of blood cancers, and it's a great chance for everyone to connect and learn from each other.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Runx1 Foundation NIH-funded |
| Lab location | 1 site (Santa Barbara, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $25,200 |
| NIH project number | 1R13CA294849-01 |
| Project ID | NIH-11000227 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals diagnosed with RUNX1 familial platelet disorder and their families.
✕Less likely to help
Patients without a diagnosis of RUNX1 familial platelet disorder or those not interested in research discussions may not benefit from this conference.
What this research studies
This conference brings together researchers, clinicians, and patients to share knowledge and data about RUNX1 familial platelet disorder, a rare condition that increases the risk of blood cancers. Participants will have the opportunity to learn about the latest research findings, engage in discussions, and network with experts in the field. The event also supports early career investigators by providing a platform for them to present their work. The conference aims to foster collaboration and advance understanding of this disorder.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with RUNX1 familial platelet disorder.
How similar studies have gone: Previous conferences have successfully fostered collaboration and knowledge sharing, indicating a positive trend in advancing research in this area.
Where this research is happening
-
Runx1 Foundation
Santa Barbara, United States Active
Researchers
- Principal investigator: Ericson, Katrin — Runx1 Foundation
- Study coordinator: Ericson, Katrin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.